Corcept Therapeutics
Subhagya Wadekar is an experienced professional in biomarker operations and clinical research, currently serving as Associate Director of Biomarkers at Corcept Therapeutics since July 2020. Previously, Subhagya held various roles at Genentech, including Clinical Biomarker Operations Manager and Project Manager for Biomarker Operations in collaborations. Prior experience includes project management in vaccine development at ImmunoScience, QC chemist at Thermo Fisher Scientific, and research positions at Roche and Capstone Therapeutics. Subhagya's academic background includes a Ph.D. in Biomedical Sciences from The University of Toledo, complemented by a postdoctoral fellowship at UCSF. Subhagya has contributed to numerous studies and publications in the field of molecular and cellular biology.
Corcept Therapeutics
4 followers
Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders.